drugset / Trial / NCT03050424

Iron and Chronic Obstructive Pulmonary Disease (COPD) Exercise Trial

NCT03050424

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This phase II single centre, double blind, placebo-controlled, randomised trial aims to test the hypothesis that intravenous iron improves exercise performance in Chronic Obstructive Pulmonary Disease (COPD) as measured by constant rate cycle ergometry.

Timeline

Start
2017-04-01
Primary completion
2018-10-01
Completion
2019-01-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ferric carboxymaltose Other / unclassified 15 mg/kg Intravenous